Safety and Tolerability Study of CTx1000 In Participants With Amyotrophic Lateral Sclerosis
NCT07401121
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
15
Enrollment
INDUSTRY
Sponsor class
Conditions
ALS (Amyotrophic Lateral Sclerosis)
Interventions
DRUG:
AAV9 Gene therapy
Sponsor
Celosia Therapeutics Pty Ltd
Collaborators
[object Object]